Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Small Biotechs Could Suffer Under State Bans On Selling Physician Rx Data, BIO Says

This article was originally published in The Pink Sheet Daily

Executive Summary

Bans on the practice, like the recently upheld New Hampshire law, could have an unintended financial consequence on small biotech companies, BIO warns.
Advertisement

Related Content

With Ban On Prescribing Data In Effect In N.H., IMS/SDI Petition Supreme Court
With Ban On Prescribing Data In Effect In N.H., IMS/SDI Petition Supreme Court
Rx Datamining Ban By N.H. Upheld On Appeal; Will Other States Follow?
Rx Datamining Ban By N.H. Upheld On Appeal; Will Other States Follow?
BIO Continues To Mull PhRMA’s Marketing Code
Mass. Ethics Code Compromises Drug Development, Industry Says

Topics

Advertisement
UsernamePublicRestriction

Register

PS068499

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel